---
layout: post
title: "Orange Book-Questions and Answers; Guidance for Industry; Availability"
date: 2026-02-05 18:59:57 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-15831
original_published: 2022-07-25 00:00:00 +0000
significance: 8.00
---

# Orange Book-Questions and Answers; Guidance for Industry; Availability

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** July 25, 2022 00:00 UTC
**Document Number:** 2022-15831

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Orange Book--Questions and Answers." This guidance is intended to assist interested parties (including prospective drug product applicants, drug product applicants, and approved application holders) in utilizing the publication Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book). This guidance finalizes the draft guidance of the same title issued on June 1, 2020.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/07/25/2022-15831/orange-book-questions-and-answers-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-15831

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
